No products in the cart.
Rabeprazole Sodium Enteric-Coated Tablets 20mg (Fushenggong) Wholesale price comparison
$3.00
Rabeprazole Sodium Enteric-Coated Tablets (brand: Fushenggong) are used in laboratory studies as proton pump inhibitors (PPIs) to model gastric acid suppression. Each box contains 2 blister packs, 6 tablets per pack.?? For experimental and research use only. ?Please consult staff for other specifications and uses?
Description
Rabeprazole Sodium Enteric Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Rabeprazole Sodium Enteric-Coated Tablets (??? / Fushenggong) |
| Common Synonyms | Rabeprazole Sodium, Rabeprazole EC, Aciphex (Brand Equivalent) |
| CAS Number | 117976-89-3 |
| Molecular Formula | C18H20N3NaO3S |
| Molecular Weight | 381.42 g/mol |
| Formulation | Enteric-coated tablet |
| Strength | 20 mg per tablet |
| Specification | 20mg × 6 tablets × 2 blisters = 12 tablets total |
| Dosage Form | Oral tablet (enteric-coated) |
| Approval Number | NMPA H20243343 |
| Drug Code | 86984194000032 |
| Manufacturer | Hunan Mingrui Pharmaceutical Co., Ltd. (????????????) |
| Barcode | 6934230600379 |
| Storage Conditions | Keep in a dry, cool environment below 25°C, protected from light |
| Intended Use | For laboratory and pharmaceutical research only |
Rabeprazole Sodium Enteric Product Description & Research Application
Rabeprazole sodium is a second-generation benzimidazole-type proton pump inhibitor (PPI), known for its strong and fast-acting suppression of gastric acid by inhibiting the H?/K?-ATPase in gastric parietal cells.
In research contexts, it is commonly applied in:
In vitro simulation of gastric acid suppression
Drug dissolution profiling in acidic pH
Bioavailability & pharmacokinetic studies
Preclinical studies of PPI-based formulations
The enteric-coated formulation ensures acid resistance, preserving active compound release in pH-sensitive in vitro models.
?? Legal Disclaimer
This product is sold strictly for laboratory research purposes. It is not intended for human ingestion, diagnosis, or therapeutic use. Misuse may result in legal and health consequences.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 20 × 26 × 22 cm |
What makes rabeprazole different from other PPIs?
Rabeprazole has a faster onset of action and higher pKa than omeprazole or lansoprazole, making it suitable for rapid acid suppression modeling.
Can you supply SDS and COA for compliance?
Yes. Both Safety Data Sheets (SDS) and Certificates of Analysis (COA) are available for qualified research users.
Do you provide wholesale pricing or OEM service?
Yes. We support bulk purchasing, OEM, and private label production upon request.
Related products
Rebamipide Tablets 0.1 g × 24 Tablets (Rebo / Shenghuaxi)
Rebamipide Tablets (brand names: Rebo / Shenghuaxi) are oral tablets containing 0.1 g (100 mg) rebamipide each, used in laboratory research focusing on gastric mucosal protection and anti-inflammatory studies. Produced by Chongqing Shenghuaxi Pharmaceutical Co., Ltd. under Chinese NMPA approval H20234327.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$3.00Pantoprazole Sodium 40?mg Enteric Capsules 14?Count (JianRongChen)
Pantoprazole Sodium Enteric Capsules (brand: JianRongChen) deliver 40?mg of pantoprazole sodium per capsule, with 14 capsules per box. Produced by Hunan JianRong Pharmaceutical Co., Ltd., NMPA registration H19990260. A proton pump inhibitor ideal for laboratory research—such as acid suppression, gastrointestinal models, pharmacokinetic/pharmacodynamic (PK/PD) studies, and drug interaction assays.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$1.20Troxipide Tablets 100?mg ×?6 Tablets (Miaoyixian) Wholesale price comparison
Troxipide Tablets (brand: Miaoyixian) are orally administered anti-ulcer agents primarily used in experimental models of gastric mucosal injury, gastritis, and NSAID-induced ulcers. Each box contains 6 tablets of 100?mg Troxipide. Manufactured by Hubei Qianjiang Pharmaceutical Co., Ltd., this product is registered under China NMPA H20010356.?? Research-use only.?Please consult staff for other specifications and uses?
$1.00Calcium Polycarbophil Tablets 0.5 g × 10 Tablets (Liweishu)
Calcium Polycarbophil Tablets (brand name: Liweishu) contain 0.5 g of calcium polycarbophil per tablet and are designed for experimental research in gastrointestinal studies and related fields. Each box includes 10 tablets. Manufactured by Zhejiang Anglikang Pharmaceutical Co., Ltd. Registered under Chinese NMPA approval H20244500.?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$2.00
Reviews
There are no reviews yet.